iMig 2025

The 17th International Conference of The International Mesothelioma Interest Group
Facebook-f Instagram X-twitter

Call for Abstracts

Abstract Submission Portal Opens in January 2025. Stay Tuned!

Submission Guidelines:

  • Research work should be original and innovative. Work can be presented prior to the iMig 2025 Conference but MUST include new information
  • Abstract will be accepted in English only
  • Abstracts should not exceed 500 words in length
  • The abstract title should not exceed 25 words
  • Tables may be included, and each will count as 100 words
  • There is a no fee for submitting an abstract
  • There is no limit to the number of co-authors per abstract
  • There is no limit to the number of abstracts you may submit
  • An international panel of reviewers will review all abstracts anonymously
  • All abstracts accepted by the Scientific Committee will be on the Conference website prior to the Conference
  • The submission of Clinical Trials in Progress is allowed
  • It is mandatory to structure abstracts as follows:
    1. Objectives
    2. Methods
    3. Results
    4. Conclusion

Submission Categories:

Abstract Submission Guidelines

To foster high-quality oral and written presentations at iMig conferences, an implementation team will conduct a review of abstract titles and provide suggestions. 

Word Limit: 

500 words (does not include title and authors) 
Abstracts should be organized in different sections based on the selected abstract type. Please refer to the ‘Abstract Type’ section on this page for further information. 

Title Word Limit: 

125 characters total (including spaces) 

Tables: 

No limit; each table counts as 100 words 

Images: 

2 maximum; each image counts as 100 words 

Format(s): 

Upload tables, images and graphs in GIF, JPEG, JPG or PNG format of a minimum of 300 dpi and 100% size. Higher resolution is acceptable and preferred. 

Language: 

English 

Fee: 

No submission fee 

Presenting Author Limit: 

Authors can only be listed as the Presenting Author on two (2) abstracts but can be co-author on any number of abstracts. 

Number of Co-authors: 

No limit of co-authors on any abstract. 

Encore Submission: 
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract. 

Financial disclosure and affiliation information is required for the presenting author.  For reference, here is a link to the disclosure form. 

Publication:
Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation. 

Education Awards:
These awards are presented to individuals with high scoring abstracts who meet categorical eligibility criteria and who apply. Applications must be completed by the abstract and education award submission deadline April 5, 2024 (23:59 PDT). 

Submission Categories

All abstracts submitted to iMig 2025 will submitted to one of the following categories: 

  • Biomakers, genetics/bioinformatics 
  • Clinical Trials 
  • Epidemiology and asbestos control 
  • Imaging 
  • Immunology 
  • Mesothelioma biology and novel targets 
  • Nursing and Allied Health 
  • Pathology 
  • Peritoneal mesothelioma 
  • Radiation concology 
  • Surgery 
  • Symptom management/pleural management 
Plagiarism Policy

Definition: 
Plagiarism encompasses all of the following: 

  1. Direct: intentionally submitting another person’s words or ideas verbatim as one’s own; 
  2. Self-plagiarism: submitting work that has been previously published or presented; 
  3. Mosaic plagiarism: stringing together portions of text from other sources; and 
  4. Lack of attribution: failing to appropriately identify and cite sources for language or ideas that are incorporated. 
  • Screening: iMig screens all abstracts using anti-plagiarism software. Abstracts identified as having high levels of plagiarized content will be evaluated by iMig staff and appropriate actions taken.
  • Penalties for plagiarism may include: Rejection of abstract, and/or author(s) banned from making presentations at future iMig conferences. 
Encore Submissions

An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract. 

All abstracts submitted to iMig 2025 will submitted to one of the following categories:

  • Mesothelioma Biology, BAP1, Pathogenesis 
  • Innovative Treatment Targets
  • Biomarkers in Mesothelioma
  • In vitro and In vivo Models in Mesothelioma
  • Epidemiology, Asbestos, and Other Factors
  • Mesothelioma Pathology and Tumor Microenvironment
  • Imaging Techniques in Mesothelioma
  • Artificial Intelligence in Mesothelioma
  • Surgery for Mesothelioma
  • Radiation and Local Ablative Therapies
  • Systemic Therapy – Treatment and Prevention
  • Immunology and Immunotherapy
  • Ongoing and Emerging Clinical Trials
  • Palliative and Supportive Care
  • Nursing & Allied Health Professionals
  • Peritoneal Mesothelioma
Scroll to Top